Factors influencing psychotropic prescription by non-psychiatrist physicians in a nursing home for the elderly in Brazil
Keywords:
Aging, Homes for the aged, Drug prescriptions, Heart diseases, PsychopharmacologyAbstract
CONTEXT AND OBJECTIVE: Although psychotro- pics are one of the classes of medications most prescribed in nursing homes for the elderly, studies examining prescribing patterns are limited in both number and scope. The present study was undertaken to investigate factors associ- ated with general psychotropic use in a nursing home in Brazil. DESIGN AND SETTING: Retrospective obser- vational study at the Nursing Home for the Elderly, Institute of Biosciences, Universidade Estadual Paulista. METHODS: Information on prescriptions was retrieved from the medical records of 108 elderly residents in a nursing home. Sixty-five of these patients, with mean age 74.5 years (± standard deviation 9.4 years), who were tak- ing medications on a regular basis, comprised the sample. The effects of demographic and clinical variables on the psychotropic prescription pattern were examined. RESULTS: Females were more likely to receive psychotropics (p = 0.038). Individuals on medicines for cardiovascular diseases received psychotropics less frequently (p = 0.001). The number of prescribed psychotropics correlated negatively with both age (p = 0.009) and number of non-psychotropic drugs (p = 0.009). CONCLUSIONS: Although preliminary, the present results indicated that cardiovascular disease was the clinical variable that most influenced psychotropic prescription. Physicians’ overconcern regarding drug interactions might at least partially explain this result. Further investigations involving larger sample sizes from different regions are warranted to confirm these findings.
Downloads
References
Snowdon J, Vaughan R, Miller R, Burgess EE, Tremlett P. Psychotropic drug use in Sydney nursing homes. Med J Aust. 1995;163(2):70-2.
Katona CL. Psychotropics and drug interactions in the elderly patient. Int J Geriatr Psychiatry. 2001;16(Suppl 1):S86-90.
Buck JA. Psychotropic drug practice in nursing homes. J Am Geriatr Soc. 1988;36(5):409-18.
Ruby CM, Kennedy DH. Psychopharmacologic medication use in nursing-home care: Indicators for surveyor assessment of the performance of drug-regimen reviews, recommendations for monitoring, and nonpharmacologic alternatives. Clin Family Practice. 2001;3:577-98.
Sorensen L, Foldspang A, Gulmann NC, Munk-Jorgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry. 2001;16(2):147-54.
Robinson MJ, Levenson JL. The use of psychotropics in the medically ill. Curr Psychiatry Rep. 2000;2(3):247-55.
Mort JR, Aparasu RR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs. 2002;16(2):99-109.
Dealberto MJ, Seeman T, McAvay GJ, Berkman L. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol. 1997;50(3):357-64.
Fichter MM, Witzke W, Leibl K, Hippius H. Psychotropic drug use in a representative community sample: the Upper Bavarian study. Acta Psychiatr Scand. 1989;80(1):68-77.
Nirodi P, Mitchell AJ. The quality of psychotropic drug prescrib- ing in patients in psychiatric units for the elderly. Aging Ment Health. 2002;6(2):191-6.
Ancill RJ, Embury GD, MacEwan GW, Kennedy JS. The use and misuse of psychotropic prescribing for elderly psychiatric patients. Can J Psychiatry. 1988;33(7):585-9.
Smid J, Nitrini R, Bahia VS, Caramelli P. Caracterização clínica da demência vascular: avaliaçäo retrospectiva de uma amostra de pacientes ambulatoriais. [Clinical characterization of vascular dementia: retrospective evaluation of an outpatient sample]. Arq Neuropsiquiatr. 2001;59(2B):390-3.
Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-inter- val abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355(9209):1048-52.
Hansen S. Mental health issues associated with cardiovas- cular disease in women. Psychiatr Clin North Am. 2003; 26(3):693-712.
Ryan JM, Kidder SW, Daiello LA, Tariot PN. Psychopharma- cologic interventions in nursing homes: what do we know and where should we go? Psychiatr Serv. 2002;53(11):1407-13.
Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol. 1999;19(2):132-40.
Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivela SL, Isoaho R. Psychotropics among the home-dwelling elderly - increasing trends. Int J Geriatr Psychiatry. 2002;17(9):874-83.
Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003;51(5):671-7.
Hohmann AA. Gender bias in psychotropic drug prescribing in primary care. Med Care. 1989;27(5):478-90.
Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13(4):243-50.
Holmquist IB, Svensson B, Hoglund P. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol. 2003;59(8- 9):669-76.
Robins LN, Helzer JE, Weissman MM, et al. Lifetime preva- lence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41(10):949-58.
van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ. 1993;307(6900):363-6.
Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA. 1984;251(3):375-9.
Verbrugge LM. Gender and health: an update on hypotheses and evidence. J Health Soc Behav. 1985;26(3):156-82.
